Travel grant, 2025, South Korea, BioKorea, May 6-9
| Reference number | |
| Coordinator | NorthX Biologics AB |
| Funding from Vinnova | SEK 25 000 |
| Project duration | May 2025 - May 2025 |
| Status | Completed |
| Venture | Global cooperation 2025 |
Important results from the project
NorthX Biologics offers process development and manufacturing for a number of biological drugs and ATMPs such as: Cell therapy Virala vectors and viruses pDNA rProteins mRNA The purpose of the trip was to find new customers in Korea, but it is premature to judge whether the trip was successful or not.
Expected long term effects
Approach and implementation
Two people from NorthX Biologics visited BioKorea in Seoul to find new customers. Everything went according to plan.